Intestinal lymphangiectasia in systemic sclerosis
Van Tilburg, A.J.; van Blankenstein, M.; Verschoor, L.
American Journal of Gastroenterology 83(12): 1418-1419
1988
ISSN/ISBN: 0002-9270 PMID: 3195550 Document Number: 311617
Protein-losing gastroenteropathy is a well-recognized entity in systemic sclerosis, for which several mechanisms have been postulated. Acquired intestinal lymphangiectasia as a cause of increased intestinal protein loss has not previously been described in the literature. We report the first case of acquired intestinal lymphangiectasia in systemic sclerosis.
Document emailed within 1 workday
Related Documents
Roggero, P.; Mangiaterra, V.; Mosca, F.; Offredi, M.L.; Perazzani, M.; Borzani, M. 1982: Ultrastructural morphological evaluation of the intestinal epithelium in subjects with gluten intolerance, giardiasis, chronic diarrhea and intestinal lymphangiectasia Minerva Pediatrica 34(4): 161-168Aguado Lorenzo, O.; Fernández-Monrás, F.; Aragó, J.V.; Rosell Abaurrea, F. 2002: Systemic sclerosis and intestinal inflammatory disease Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 94(6): 372-373
Otsuka, S. 1994: Intestinal lymphangiectasia Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 6: 588-590
Banatwala, N.S.; Zuberi, S.J. 1980: Intestinal lymphangiectasia: a case report Jpma. Journal of the Pakistan Medical Association 30(10): 231-234
Yueh, T.C.; Pui, M.H.; Zeng, S.Q. 1997: Intestinal lymphangiectasia: value of Tc-99m dextran lymphoscintigraphy Clinical Nuclear Medicine 22(10): 695-696
Uras, C.; Tabolli, S.; Giannantoni, P.; Rocco, G.; Abeni, D. 2014: The Italian version of the Systemic Sclerosis Questionnaire: a comparison of quality of life in patients with systemic sclerosis and with other connective tissue disorders Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(5): 539-548
Olson, N.C.; Zimmer, J.F. 1978: Protein-losing enteropathy secondary to intestinal lymphangiectasia in a dog Journal of the American Veterinary Medical Association 173(3): 271-274
Ploier, R. 1972: Protein losing enteropathy in primary intestinal lymphangiectasia Wiener Klinische Wochenschrift 84(36): 561-564
Mwaungulu, G.S.; Lucas, S.B. 1982: Intestinal lymphangiectasia: a case report at Kenyatta National Hospital East African Medical Journal 59(2): 157-160
Baron, M.; Bernier, P.; Côté, L-François.; Delegge, M.H.; Falovitch, G.; Friedman, G.; Gornitsky, M.; Hoffer, J.; Hudson, M.; Khanna, D.; Paterson, W.G.; Schafer, D.; Toskes, P.P.; Wykes, L. 2010: Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel Clinical and Experimental Rheumatology 28(2 Suppl. 58): S42-S46
Stepień, M.; Cendrowski, W. 1974: Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis Neurologia i Neurochirurgia Polska 8(4): 607-609
Gawrysiak, W.; Skrypnik, K.; Suliburska, J.; Skrypnik, D.; Bogdański, Pł. 2017: Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis Przeglad Lekarski 74(4): 179-182
Obata, T.; Takahashi, H.; Nosho, K.; Ikeda, Y.; Tokuno, T.; Kawahito, Y.; Honda, S.; Makiguchi, Y.; Imai, K.; Ikeda, T. 1998: A case of systemic lupus erythematosus overlapping with progressive systemic sclerosis accompanied by deposition of AA amyloid in the stomach Ryumachi 38(6): 810-817
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Paradowska-Gorycka, A.; Wajda, A.; Stolarek, I.; Felis-Giemza, A.; Walczyk, M.; Nałecz-Janik, J.; Olesińska, M. 2019: Is the T-G-CT-G SNRNP70 haplotype another proof that mixed connective tissue disease is distinct from systemic lupus erythematosus and systemic sclerosis? a novel gene variant in SNRNP70 gene Clinical and Experimental Rheumatology 37 Suppl 119(4): 32-40
Gustafsson, R. 1994: Systemic sclerosis Nordisk Medicin 109(8-9): 236-237
Martinez-Cordero, E.; Fonseca, M.C.; Aquilar León, D.E.; Padilla, A. 1993: Juvenile systemic sclerosis Journal of Rheumatology 20(2): 405-407
Carpentier, P.H.; Maricq, H.R. 1990: Microvasculature in systemic sclerosis Rheumatic Diseases Clinics of North America 16(1): 75-91
Nakajima, A.; Koseki, Y.; Suwa, A.; Imaeda, H.; Okamura, T.; Tsutsumino, M.; Sendo, W.; Terai, C.; Hara, M.; Kashiwazaki, S.; Inada, S. 1998: Pneumoperitoneum with systemic sclerosis Ryumachi 38(6): 825-830